cortex phellodendrine
Botanicalexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2010 (NCT01138436)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cortex phellodendri
- cortex phellodendrine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01297400 | Phase 2 | Jan 2, 2018 | Skingenix, Inc. |
| NCT02545777 | Phase 2 | May 1, 2014 | Peking University |
| NCT01070433 | Phase 2 | Sep 1, 2012 | Skingenix, Inc., University of Miami |
| NCT01138436 | Phase 2 | Nov 1, 2010 | Skingenix, Inc., University of Miami |
| NCT01154374 | Phase 2 | Nov 1, 2010 | Skingenix, Inc., University of Miami |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Skingenix, Inc. | For profit | 4 | 4 | 1 | 2010 |
| University of Miami | Academic/Hospital | 3 | 0 | 1 | 2010 |
| Peking University | Academic/Hospital | 1 | 1 | 1 | 2014 |
3 organizations
Page 1 / 1